Evidence map›Paper›PMID 26521658›Full record

ArticleJournal of industrial microbiology & biotechnology2016

Controlling the transcription levels of argGH redistributed L-arginine metabolic flux in N-acetylglutamate kinase and ArgR-deregulated Corynebacterium crenatum.

Qinqin Zhao, Yuchang Luo, Wenfang Dou, Xian Zhang, Xiaomei Zhang, Weiwei Zhang, Meijuan Xu, Yan Geng, Zhiming Rao, Zhenghong Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Production of l-glutamate family amino acids inSynthetic and systems biotechnology · 2021
    Review
  3. Development of a Novel Biosensor-Driven Mutation and Selection System viaFrontiers in bioengineering and biotechnology · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Qinqin ZhaoSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China.
Yuchang LuoSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China.
Wenfang DouSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China.
Xian ZhangKey Laboratory of Industrial Biotechnology of Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Xiaomei ZhangSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China.
Weiwei ZhangSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China.
Meijuan XuKey Laboratory of Industrial Biotechnology of Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, People's Republic of China.
Yan GengSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China.
Zhiming RaoKey Laboratory of Industrial Biotechnology of Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, People's Republic of China. raozhm@jiangnan.edu.cn.
Zhenghong XuSchool of Pharmaceutical Science, Jiangnan University, Wuxi, 214122, People's Republic of China. zhenghxu@jiangnan.edu.cn.
Jiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corynebacterium crenatum SYPA5-5, an L-arginine high-producer obtained through multiple mutation-screening steps, had been deregulated by the repression of ArgR that inhibits L-arginine biosynthesis at genetic level. Further study indicated that feedback inhibition of SYPA5-5 N-acetylglutamate kinase (CcNAGK) by L-arginine, as another rate-limiting step, could be deregulated by introducing point mutations. Here, we introduced two of the positive mutations (H268N or R209A) of CcNAGK into the chromosome of SYPA5-5, however, resulting in accumulation of large amounts of the intermediates (L-citrulline and L-ornithine) and decreased production of L-arginine. Genetic and enzymatic levels analysis involved in L-arginine biosynthetic pathway of recombinants SYPA5-5-NAGKH268N (H-7) and SYPA5-5-NAGKR209A (R-8) showed that the transcription levels of argGH decreased accompanied with the reduction of argininosuccinate synthase and argininosuccinase activities, respectively, which led to the metabolic obstacle from L-citrulline to L-arginine. Co-expression of argGH with exogenous plasmid in H-7 and R-8 removed this bottleneck and increased L-arginine productivity remarkably. Compared with SYPA5-5, fermentation period of H-7/pDXW-10-argGH (H-7-GH) reduced to 16 h; meanwhile, the L-arginine productivity improved about 63.6%. Fed-batch fermentation of H-7-GH in 10 L bioreactor produced 389.9 mM L-arginine with the productivity of 5.42 mM h(-1). These results indicated that controlling the transcription of argGH was a key factor for regulating the metabolic flux toward L-arginine biosynthesis after deregulating the repression of ArgR and feedback inhibition of CcNAGK, and therefore functioned as another regulatory mode for L-arginine production. Thus, deregulating all these three regulatory modes was a powerful strategy to construct L-arginine high-producing C. crenatum.

Indexed as

Metabolic Flux AnalysisTranscription, GeneticArginineArgininosuccinate LyaseArgininosuccinate SynthaseBacterial ProteinsBiosynthetic PathwaysCitrullineCorynebacteriumFeedback, PhysiologicalFermentationGene Expression Regulation, BacterialGenes, BacterialOrnithinePhosphotransferases (Carboxyl Group Acceptor)acetylglutamate kinaseArginineArgininosuccinate LyaseArgininosuccinate SynthaseBacterial ProteinsCitrullineOrnithinePhosphotransferases (Carboxyl Group Acceptor)argGHCorynebacterium crenatumFeedback inhibitionL-arginineL-citrullineL-ornithine

Identifiers

PMID26521658
OpenAlexW2231860331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.